Published on 29 December 2022
The importance of trust
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2022.1103.014
1.505 views
Published on 29 December 2022
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2022.1103.014
1.505 views
Published on 29 November 2022
1.018 views
Published on 29 November 2022
797 views
Published on 24 November 2022
bioequivalence, new branded generics, pharmacokinetics, sitagliptin
DOI: 10.5639/gabij.2023.1201.003
3.223 views
Published on 26 September 2022
Author(s): Mihaela Buda, PhD
flexibility, infliximab, monographs, pharmacopoeia, public standards, reference preparations
DOI: 10.5639/gabij.2022.1103.017
4.518 views
Published on 08 September 2022
Author(s): Professor James C Robinson, PhD, MPH
biosimilars, Germany, healthcare costs, Italy, medicine prices, social trust
DOI: 10.5639/gabij.2022.1103.015
4.877 views
Published on 08 September 2022
biosimilars, interchangeability, substitution, switching, US
DOI: 10.5639/gabij.2022.1103.016
4.114 views
Published on 08 September 2022
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2022.1102.008
1.268 views
Published on 19 August 2022
Author(s): Richard L Easton, BSC (Hons), DIC, PhD
analytics, biosimilars, functional testing, orthogonality, structural characterization
DOI: 10.5639/gabij.2022.1102.013
1.673 views
Published on 19 August 2022
Author(s): Michael S Reilly, Esq, Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP
biosimilars, health policies, physicians, prescribing, uptake
DOI: 10.5639/gabij.2022.1103.018
7.057 views
Published on 01 August 2022
biosimilars, interchangeability, logarithmic transformation, statistical evaluation
DOI: 10.5639/gabij.2022.1102.010
2.820 views
Published on 19 July 2022
Australia, interchangeability, substitution
DOI: 10.5639/gabij.2022.1102.009
3.417 views